Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren Arancini

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Trials|September 11, 2019
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trialLauren Arancini, Chiara C Bortolasci, Seetal Dodd, et al.
Journal of Affective Disorders|August 27, 2018
A review of the neurobiological underpinning of comorbid substance use and mood disordersNieves Gómez-Coronado, Rickinder Sethi, Chiara Cristina Bortolasci, et al.
Expert Opinion on Pharmacotherapy|November 30, 2018
Considerations when selecting pharmacotherapy for nicotine dependenceSeetal Dodd, Lauren Arancini, Nieves Gómez-Coronado, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 10, 2021
A placebo-controlled, randomised pilot trial of N-acetylcysteine or placebo for cessation of tobacco smokingLauren Arancini, Mohammadreza Mohebbi, Michael Berk, et al.
Addiction (Abingdon, England)|March 2, 2021
Age as a predictor of quit attempts and quit success in smoking cessation: findings from the International Tobacco Control Four-Country survey (2002-14)Lauren Arancini, Ron Borland, Michael Le Grande, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Trials|September 11, 2019
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trialLauren Arancini, Chiara C Bortolasci, Seetal Dodd, et al.
Journal of Affective Disorders|August 27, 2018
A review of the neurobiological underpinning of comorbid substance use and mood disordersNieves Gómez-Coronado, Rickinder Sethi, Chiara Cristina Bortolasci, et al.
Expert Opinion on Pharmacotherapy|November 30, 2018
Considerations when selecting pharmacotherapy for nicotine dependenceSeetal Dodd, Lauren Arancini, Nieves Gómez-Coronado, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 10, 2021
A placebo-controlled, randomised pilot trial of N-acetylcysteine or placebo for cessation of tobacco smokingLauren Arancini, Mohammadreza Mohebbi, Michael Berk, et al.
Addiction (Abingdon, England)|March 2, 2021
Age as a predictor of quit attempts and quit success in smoking cessation: findings from the International Tobacco Control Four-Country survey (2002-14)Lauren Arancini, Ron Borland, Michael Le Grande, et al.
Pageof 1